Works by Vall-Llovera, Ferran
Results: 20
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
- Published in:
- Annals of Hematology, 2018, v. 97, n. 11, p. 2089, doi. 10.1007/s00277-018-3413-7
- By:
- Publication type:
- Article
A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 7, p. 2317, doi. 10.1002/cam4.2814
- By:
- Publication type:
- Article
Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910
- By:
- Publication type:
- Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 9, p. 1660, doi. 10.1002/cncr.27918
- By:
- Publication type:
- Article
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
- By:
- Publication type:
- Article
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
- Published in:
- 2018
- By:
- Publication type:
- Erratum
An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 10, p. 2059, doi. 10.1007/s00432-017-2445-z
- By:
- Publication type:
- Article
Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 1, p. 79, doi. 10.1111/ejh.13178
- By:
- Publication type:
- Article
Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 7, p. 1634, doi. 10.1080/10428194.2017.1397661
- By:
- Publication type:
- Article
Bilateral phrenic nerve palsy induced by subcutaneous bortezomib in a patient with newly diagnosed multiple myeloma: first case reported.
- Published in:
- Leukemia & Lymphoma, 2017, v. 58, n. 2, p. 482, doi. 10.1080/10428194.2016.1195496
- By:
- Publication type:
- Article
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients.
- Published in:
- Leukemia & Lymphoma, 2014, v. 55, n. 10, p. 2341, doi. 10.3109/10428194.2013.878933
- By:
- Publication type:
- Article
Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.
- Published in:
- Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1706, doi. 10.3109/10428194.2012.752080
- By:
- Publication type:
- Article
Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.
- Published in:
- Leukemia & Lymphoma, 2013, v. 54, n. 2, p. 1, doi. 10.3109/10428194.2012.752080
- By:
- Publication type:
- Article